Related Experiment Videos
Associations between ERCC2 polymorphisms and gliomas
M Caggana1, J Kilgallen, J M Conroy
1Division of Genetic Disorders, New York State Department of Health, Wadsworth Center, Albany 12201-0509, USA.
Summary
Genetic variations in the ERCC2 gene may influence glioma risk. A study found a link between a specific ERCC2 variant and increased odds of developing oligoastrocytoma, suggesting a potential role in glioma development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The ERCC2 gene is crucial for DNA repair and transcription.
- Mutations in ERCC2 cause severe genetic disorders like xeroderma pigmentosum.
- ERCC2 polymorphisms' functional impact on glioma risk is largely unknown.
Purpose of the Study:
- To investigate the association between ERCC2 gene sequence variations and adult-onset gliomas.
- To determine if specific ERCC2 polymorphisms increase or decrease glioma susceptibility.
Main Methods:
- A case-control study involving 187 glioma patients and 169 healthy controls.
- Genotyping of seven known ERCC2 polymorphisms (R156R, I199M, H201Y, D312N, A575A, D711D, K751Q).
- Identification of a novel R616C polymorphism and analysis of its association with glioma risk.
Main Results:
- A significant association was found between the silent AA variant at ERCC2 codon 156 and increased glioma risk (OR 2.3).
- The strongest association was observed in oligoastrocytoma patients (OR 3.2).
- No significant overall association was found for variants at D312N, D711D, and K751Q.
Conclusions:
- Constitutive ERCC2 sequence variations, particularly the R156R silent variant, may play a role in glioma development.
- The findings suggest ERCC2 variants could be involved in glioma prevention or causation.
- Further research is needed to confirm the role of ERCC2 and potentially linked genes in glioma etiology.